which is the antipsychotic which selectively acts on the mesolimbic pathway and does not inhibit dopamin in mesocoical pathaway
## **Core Concept**
The question targets the understanding of antipsychotic drugs' mechanisms of action, particularly their effects on dopamine pathways in the brain. Antipsychotics are known to act primarily by blocking dopamine D2 receptors. The brain has several dopamine pathways, including the mesolimbic, mesocortical, nigrostriatal, and tuberoinfundibular pathways. The mesolimbic pathway is associated with the positive symptoms of schizophrenia, while the mesocortical pathway is linked to negative symptoms and cognitive deficits.
## **Why the Correct Answer is Right**
Clozapine is noted for its selective action on the mesolimbic pathway with minimal effect on the nigrostriatal pathway, which explains its lower propensity to cause extrapyramidal side effects (EPS) compared to typical antipsychotics. It has a higher affinity for dopamine D4 receptors than D2 receptors, which may contribute to its effectiveness in treating both positive and negative symptoms of schizophrenia. Clozapine's unique pharmacological profile allows it to improve schizophrenia symptoms with a lower risk of causing EPS, making it an atypical antipsychotic.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because Haloperidol is a typical antipsychotic that does not selectively act on the mesolimbic pathway; it has a high affinity for D2 receptors in all pathways, leading to a high risk of EPS.
- **Option B:** This option is incorrect because Risperidone, although an atypical antipsychotic, can cause significant EPS at higher doses due to its potent D2 receptor antagonism, indicating it does not selectively spare the mesocortical pathway.
- **Option D:** This option is incorrect because Olanzapine, while having a lower risk of EPS compared to typical antipsychotics, does not have as selective an effect on the mesolimbic pathway as Clozapine and can affect multiple receptor types.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Clozapine is specifically indicated for treatment-resistant schizophrenia and has a unique side effect profile that includes agranulocytosis, requiring regular monitoring of blood counts. Its use is limited due to these risks but offers significant benefits for patients who do not respond to other treatments.
## **Correct Answer:** C. Clozapine.